Paper30911978
Causes, consequences, and therapy of tumors acidosis.
Pillai SR and 5 others. Cancer Metastasis Rev, 2019. Cited by 220 papers, by iCite.
Cite this record
ConductScience Library. Causes, consequences, and therapy of tumors acidosis. Papers, record 30911978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30911978
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acidosis | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Buffers | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Neoplasm Invasiveness | |
| Neoplasm Metastasis |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA077575 | NCI NIH HHS | United States | R01CA077575 | PubMed and NIH | NIH RePORTER |
| U54 CA193489 | NCI NIH HHS | United States | U54CA193489 | PubMed and NIH | NIH RePORTER |
References171
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15516961 | Why do cancers have high aerobic glycolysis? | Nat Rev Cancer | 2004 | https://conductscience.org/library/papers/15516961 | PubMed |
| 2 | 16707446 | Acid-mediated tumor invasion: a multidisciplinary study. | Cancer Res | 2006 | https://conductscience.org/library/papers/16707446 | PubMed |
| 3 | 17000864 | The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. | Mol Pharmacol | 2006 | https://conductscience.org/library/papers/17000864 | PubMed |
| 4 | 24788003 | Na+,HCO3- -cotransport is functionally upregulated during human breast carcinogenesis and required for the inverted pH gradient across the plasma membrane. | Pflugers Arch | 2015 | https://conductscience.org/library/papers/24788003 | PubMed |
| 5 | 22289741 | Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. | Oncotarget | 2012 | https://conductscience.org/library/papers/22289741 | PubMed |
| 6 | 30538244 | Bioconjugation strategy for cell surface labelling with gold nanostructures designed for highly localized pH measurement. | Nat Commun | 2018 | https://conductscience.org/library/papers/30538244 | PubMed |
| 7 | 25403912 | Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin. | Cancer Res | 2015 | https://conductscience.org/library/papers/25403912 | PubMed |
| 8 | 23862567 | Polydatin: a review of pharmacology and pharmacokinetics. | Pharm Biol | 2013 | https://conductscience.org/library/papers/23862567 | PubMed |
| 9 | 26341193 | Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach. | Drug Resist Updat | 2015 | https://conductscience.org/library/papers/26341193 | PubMed |
| 10 | 28164346 | Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome. | Aliment Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28164346 | PubMed |
| 11 | 29891961 | Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow. | Nat Rev Cancer | 2018 | https://conductscience.org/library/papers/29891961 | PubMed |
| 12 | 25720462 | Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion. | J Pharm Sci | 2015 | https://conductscience.org/library/papers/25720462 | PubMed |
| 13 | 25657334 | Magnetic resonance spectroscopy for detection of choline kinase inhibition in the treatment of brain tumors. | Mol Cancer Ther | 2015 | https://conductscience.org/library/papers/25657334 | PubMed |
| 14 | 22360553 | A rationale for the use of proton pump inhibitors as antineoplastic agents. | Curr Pharm Des | 2012 | https://conductscience.org/library/papers/22360553 | PubMed |
| 15 | 28385782 | Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma. | Haematologica | 2017 | https://conductscience.org/library/papers/28385782 | PubMed |
| 16 | 19276380 | The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. | Cancer Res | 2009 | https://conductscience.org/library/papers/19276380 | PubMed |
| 17 | 16175178 | The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. | Nat Rev Cancer | 2005 | https://conductscience.org/library/papers/16175178 | PubMed |
| 18 | 25849885 | Low pH increases the yield of exosome isolation. | Biochem Biophys Res Commun | 2015 | https://conductscience.org/library/papers/25849885 | PubMed |
| 19 | 19366680 | Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19366680 | PubMed |
| 20 | 28665575 | A pH-Responsive Yolk-Like Nanoplatform for Tumor Targeted Dual-Mode Magnetic Resonance Imaging and Chemotherapy. | ACS Nano | 2017 | https://conductscience.org/library/papers/28665575 | PubMed |
Cited by155
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 220 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42935756 | Metabolic sensing in 3D models of pancreatic ductal adenocarcinoma: probing pH, oxygen, and lactate dynamics to decode chemoresistance. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42935756 | PubMed |
| 42798475 | Acidosis promotes exon skipping through sequestering SR-rich splicing factors in nuclear speckles. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42798475 | PubMed |
| 42558704 | Mechanistic role of glycolytic pathways in the tumor microenvironment in driving chemoresistance. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42558704 | PubMed |
| 42510591 | Ferroptosis Resistance: Redundant Antioxidant Networks Are a Barrier to Cancer Therapy. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42510591 | PubMed |
| 42509831 | Intercalated Motifs Contribute to Transcription Regulation in an Acidosis Model. | Biomolecules | 2026 | https://conductscience.org/library/papers/42509831 | PubMed |
| 42446762 | Rewiring cancer cell fate toward vasculogenic mimicry: from classical to unconventional processes. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42446762 | PubMed |
| 42417207 | Self-Propagating Acid Avalanche Unleashes Endogenous Iron to Fuel Potentiated Chemodynamic Therapy. | Small | 2026 | https://conductscience.org/library/papers/42417207 | PubMed |
| 42218675 | 3D bioprinted in vitro models in cancer metabolism research. | Magy Onkol | 2026 | https://conductscience.org/library/papers/42218675 | PubMed |
| 42193876 | Acidosis Drives Vasculogenic Mimicry in PDAC CSCs via Na+/H+ Exchanger Isoform 1 (NHE1) and Calcium Entry. | Cells | 2026 | https://conductscience.org/library/papers/42193876 | PubMed |
| 42159342 | Acidosis Regulates Microtubule Dynamics via the β1 Integrin/RhoA/CRMP-2 Axis. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/42159342 | PubMed |
| 41840642 | tLyP-1 peptide-modified MnO₂ co-delivering si-SLC16A1 and temozolomide synergistically suppresses glioblastoma via hypoxia modulation and metabolic stress. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41840642 | PubMed |
| 41576171 | Oxidation-activated nanotherapy boosts tumor immunity and disrupts tumor-nerve crosstalk to combat bone metastases and cancer pain. | Sci Adv | 2026 | https://conductscience.org/library/papers/41576171 | PubMed |
| 41375084 | Low pH, High Stakes: A Narrative Review Exploring the Acid-Sensing GPR65 Pathway as a Novel Approach in Renal Cell Carcinoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41375084 | PubMed |
| 41081600 | The influence of TC0668 on glycometabolism modulation in Chlamydia muridarum-infected host cells. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/41081600 | PubMed |
| 41019982 | Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance. | Cancer Drug Resist | 2025 | https://conductscience.org/library/papers/41019982 | PubMed |
| 41006825 | The opportunities and barriers for developing tumour-infiltrating lymphocyte therapy for patients with advanced genitourinary cancers. | Nat Rev Urol | 2026 | https://conductscience.org/library/papers/41006825 | PubMed |
| 40869021 | Targeting pH Inversion in Prostate Cancer Cells: A Role for Systems of Molecules of Vegetal Origin. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869021 | PubMed |
| 40867621 | Cell Settling, Migration, and Stochastic Cancer Gene Expression Suggest Potassium Membrane Flux May Initiate pH Reversal. | Biomolecules | 2025 | https://conductscience.org/library/papers/40867621 | PubMed |
| 40847194 | Beyond the obvious: targeting the SLC transportome and non-canonical drug transport mechanisms in cancer therapy. | Invest New Drugs | 2025 | https://conductscience.org/library/papers/40847194 | PubMed |
| 40739238 | Sonodynamic biomimetic-nanomedicine fight cancers. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40739238 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30911978
GET https://conductscience.org/api/papers/v1/30911978/references?page=2